Table 2.
A. Comparison of M- and S-type samples, using Mann–WhitneyUtest/Independentt-test | ||||||
---|---|---|---|---|---|---|
Variable |
Sample size (n) Sample type |
Median (IQR)1Sample type |
Mann– Whitney U |
p-value Exact Sign. (2-tailed) |
||
M | S | M | S | |||
β-F1-ATPsynth. |
18 |
9 |
0.74 (0.76) |
0.66 (0.86) |
72.0 |
0.659 |
100 K |
18 |
9 |
1.9 (9.6) |
29 (33.15) |
33.0 |
0.012 * |
ABCG2 |
18 |
9 |
0.17 (0.63) |
0.06 (0.26) |
52.5 |
0.148 |
CD44 |
18 |
9 |
0.13 (0.20) |
0.00 (0.00) |
8.50 |
<0.001 ** |
E-cadherin |
18 |
9 |
0.71 (5.2) |
8.6 (7.2) |
31.0 |
0.009 ** |
Nanog |
18 |
9 |
0.52 (0.72) |
0.92 (2.21) |
70.5 |
0.605 |
Oct-4A |
18 |
9 |
1.1 (3.0) |
0.02 (0.48) |
26.0 |
0.003 ** |
SUMO-Oct-4A |
18 |
9 |
0.96 (1.0) |
0.45 (0.80) |
34.0 |
0.014 * |
TFAM |
18 |
9 |
0.77 (1.0) |
0.51 (2.0) |
79.0 |
0.929 |
Vimentin |
18 |
9 |
0.69 (0.8) |
0.05 (0.10) |
11.0 |
<0.001 ** |
Variable |
Sample size (n) Sample type |
Mean (± Std.deviation) Sample type |
t-value |
p-value Signif. (2-tailed) |
||
M |
S |
M |
S |
|||
α-SMA |
17 |
8 |
1.8(±1.1) |
0.86(±0.30) |
3.042 |
0.0062 ** |
EpCAM |
18 |
9 |
0.90(±0.47) |
0.87(±0.44) |
0.130 |
0.8973 |
Variable |
Sample size (n) Clinical stage |
Mean (± Std.deviation) Clinical stage |
t-value |
p-value Signif. (2-tailed) |
||
IIIC |
IV |
IIIC |
IV |
|||
α-SMA | 17 | 8 | 1.1(±0.67) | 2.3(±0.46) | −2.401 | 0.0062 ** |
1 IQR: Inter-quartile range.
2 Equal variances not assumed.
3 Equal variances assumed.